Page 1

ResearchAarkstoreEnterprise Disease and Therapy Review: Multiple Sclerosis

http://www.aarkstore.com/publishers/pubreports.asp? PubId=38&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Disease&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Therapy%20&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Review&PubId=&pagenum=1 The Multiple Sclerosis Disease and Therapy Review provides and overview of the disease and its types, global patterns and incidence and prevalence numbers for major countries worldwide. Information on treatment is provided, as well as treatment and dosing costs of MS drugs. General information on the MS market, as well as sales of leading drugs and therapies are provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.


Table of Contents : I. OVERVIEW

II. INCIDENCE AND PREVALENCE - Incidence Table: (US, UK, Spain, Worldwide) - Prevalence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Worldwide)

III. TREATMENT - Beta-Interferon Products - Copaxone - Novantrone - Tysabri - Steroid Treatment

IV. DOSING

V. TREATMENT COSTS

VI. MARKET SIZE

VII. COMMENTS


VIII. REFERENCES/RESOURCES

For more information please visit link: http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Multiple-Sclerosis-12804.html Neel Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://www.facebook.com/aarkstoreenterprise

Disease and Therapy Review: ESRD Disease and Therapy Review: Alzheimer Disease Disease and Therapy Review: Migraine Disease and Therapy Review: Stroke Disease and Therapy Review: Rheumatoid Arthritis Disease and Therapy Review: Obesity Disease and Therapy Review:Major Depressive Disorder Disease and Therapy Review: HIV/AIDS Disease and Therapy Review: Epilepsy Disease and Therapy Review: Parkinson's Disease Disease and Therapy Review: Heart Failure Disease and Therapy Review: Hepatitis C Disease and Therapy Review: Bipolar Disorder Disease and Therapy Review: Breast Cancer Asthma – Executive Market Summary 2011 Bladder Cancer – Executive Market Summary 2011 Colorectal Cancer – Executive Market Summary 2011


Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011 Onychomycosis – Executive Market Summary 2011 Ulcerative Colitis – Executive Market Summary 2011 Impetigo – Executive Market Summary 2011

ResearchAarkstoreEnterprise Disease and Therapy Review Multiple Sclerosis  
Read more
Read more
Similar to
Popular now
Just for you